Rua Bioscience Limited engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally. The company offers cannabinoid derived medicines. It is also involved in seed production and genetic discovery related activities. In addition, the company engages in plant breeding business, as well as involved in plant research activities. Rua Bioscience Limited was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. The company was founded in 2016 and is based in Gisborne, New Zealand.
Metrics to compare | RUA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRUAPeersSector | |
---|---|---|---|---|
P/E Ratio | −2.4x | 4.5x | −0.5x | |
PEG Ratio | −0.03 | 0.04 | 0.00 | |
Price/Book | 1.8x | 1.6x | 2.6x | |
Price / LTM Sales | 10.6x | 1.7x | 3.3x | |
Upside (Analyst Target) | - | 38.2% | 43.5% | |
Fair Value Upside | Unlock | 10.1% | 6.3% | Unlock |